Celularity Inc — Regulatory Filings 2021

Jun 23, 2021

CORRESP 1 filename1.htm

GX Acquisition Corp.

1325 Avenue of the Americas, 25th Floor

New York, NY 10019

June 23, 2021

VIA EDGAR SUBMISSION

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn:
Chris Edwards
Jenn Do
Kate Tillan

RE:
Registration Statement on Form S-4 (the “Registration Statement”)
File No. 333-252402

Ladies and Gentlemen:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of the effectiveness of the above-referenced Registration Statement such that the Registration Statement will become effective as of 12:00 P.M. Eastern Standard Time on Friday, June 25, 2021, or as soon thereafter as practicable.

Please contact C. Michael Chitwood of Skadden, Arps, Slate, Meagher & Flom LLP at (212) 735-2535 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.

Very truly yours,
GX ACQUISITION CORP.
By:	/s/ Jay R. Bloom
Name:	Jay R. Bloom
Title:	Co-Chairman and Chief Executive Officer

cc:
GX Acquisition Corp.

cc:
Skadden, Arps, Slate, Meagher & Flom LLP